Applied Drug Research, Clinical Trials and Regulatory Affairs is an international journal with vast readership and contributions that are scientific, original, relevant, innovative and statistically validated. The journal aims to further bridge the gap in the publication of clinical drug development, biotherapeutics and regulatory affairs between high growth and potentially growing regions.
The journal Applied Drug Research, Clinical Trials and Regulatory Affairs publishes innovative, developmental and original research on validated experimental design, methods, representation, debates and interpretation of drug development research and drug research failures. The journal publishes original research articles, full-length/mini reviews, short communications and thematic journal issues. Published work is based on solid clinical, scientific and statistically relevant results that lead to advancements in drug development for clinical medicine, clinical trials, post marketing drug reports, drug delivery devices, pharmaceutical engineering, dissemination of trial results, innovation, regulatory affairs and human subject protection.
Applied Clinical Research, Clinical Trials and Regulatory Affairs, was introduced in 2014 and later renamed in 2020 as Applied Drug Research, Clinical Trials and Regulatory Affairs with the assistance of Dr. Satish C. Nair, who is the current Editor-in-Chief serving since 2014.